An n-of-1 Trial Service in Clinical Practice: Testing the Effectiveness of Stimulants for Attention-Deficit/Hyperactivity Disorder
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
OBJECTIVE. We sought to describe the clinical use of n-of-1 trials for attention-deficit/hyperactivity disorder in publicly and privately funded family and specialized pediatric practice in Australia. METHODS. We used a within-patient randomized, double-blind, crossover comparison of stimulant (dexamphetamine or methylphenidate) versus placebo or alternative stimulant using 3 pairs of treatment periods. Trials were conducted from a central location using mail and telephone communication, with local supervision by the patients’ clinicians. PATIENTS. Our study population included children with clinically diagnosed attention-deficit/hyperactivity disorder who were aged 5 to 16 years and previously stabilized on an optimal dose of stimulant. They were selected because treatment effectiveness was uncertain. MAIN OUTCOME MEASURES. Our measures included number of patients recruited, number of doctors who used the service, geographic spread, completion rates, response rate, and post–n-of-1 trial decisions. RESULTS. Forty-five doctors across Australia requested 108 n-of-1 trials, of which 86 were completed. In 69 drug-versus-placebo comparisons, 29 children responded better to stimulant than placebo. Immediately posttrial, 19 of 25 drug-versus-placebo responders stayed on the same stimulant, and 13 of 24 nonresponders ceased or switched stimulants. In 40 of 63 for which data were available, posttrial management was consistent with the trial results. For all types of n-of-1 trials, management changed for 28 of 64 children for whom information was available. DISCUSSION. Attention-deficit/hyperactivity disorder n-of-1 trials can be implemented successfully by mail and telephone communication. This type of trial can be valuable in clarifying treatment effect when it is uncertain, and in this series, they had a noticeable impact on short-term management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830
Conners, C. K., Sitarenios, G., Parker, J. D. A., & Epstein, J. N. (1998) · Journal of Abnormal Child Psychology · doi:10.1023/a:1022606501530 · Cited by 678
Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders?
Elia, J., Borcherding, B. G., Rapoport, J. L., & Keysor, C. S. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90126-a · Cited by 294
Chan, E., Zhan, C., & Homer, C. J. (2002) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.156.5.504 · Cited by 183
Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD
Arnold, L. E., Elliott, M., Sachs, L., Bird, H., Kraemer, H. C., Wells, K. C., Abikoff, H. B., Comarda, A., Conners, C. K., Elliott, G. R., et al. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.4.713 · Cited by 159
Quality of life of adolescent males with Attention-Deficit Hyperactivity Disorder
Topolski, T. D., Edwards, T. C., Patrick, D. L., Varley, P., Way, M. E., & Buesching, D. P. (2004) · Journal of Attention Disorders · doi:10.1177/108705470400700304 · Cited by 73
Research works printed but not linked: 27
- Barbaresi W, Katusic S, Colligan R, et al. How common is attention-deficit/hyperactivity disorder? Towards resolution of the controversy: results from a population-based study. Acta Paediatr Suppl. 2004;93(445):55–59 · DOI · Paper page
- Graetz BW, Sawyer MG, Hazell PL, Arney F, Baghurst P. Validity of DSM-IV ADHD subtypes in a nationally representative sample of Australian children and adolescents. J Am Acad Child Adolesc Psychiatry. 2001;40:1410–1417 · DOI · Paper page
- Mannuzza S, Klein R, Bessler A, Malloy P, Hynes M. Educational and occupational outcomes of hyperactive boys grown up. J Am Acad Child Adolesc Psychiatry. 1997;36:1222–1227 · DOI · Paper page
- Sawyer MG, Rey JM, Graetz BW, Clark JJ, Baghurst PA. Use of medication by young people with attention-deficit/hyperactivity disorder. Med J Aust. 2002;177:21–25 · DOI
- Kent MA, Camfield CS, Camfield PR. Double-blind methylphenidate trials: practical, useful and endorsed by families. Arch Pediatr Adolesc Med. 1999;153:1292–1296 · DOI · Paper page
- Berbatis CG, Sunderland VB, Bulsara M. Licit psychostimulant consumption in Australia, 1984–2000: international and jurisdictional comparison. Med J Aust. 2002;177:539–543 · DOI
- Sheather-Reid RB, Cohen ML. Efficacy of analgesics in chronic pain: a series of N-of-one studies. J Pain Symptom Manage. 1998;15:244–252 · doi:10.1016/s0885-3924(98)00369-8
- Mahon JM, Laupacis A, Donner A, Wood T. Randomised study of n-of-1 trials versus standard practice [published correction appears in BMJ. 1996;312:1392]. BMJ. 1996;312:1069–1074 · DOI · Paper page
- Barbaresi WJ. Primary-care approach to the diagnosis and management of attention-deficit hyperactivity disorder. Mayo Clin Proc. 1996;71:463–471 · DOI
- McBride MC. An individual double-blind crossover trial for assessing dexamphetamine response in children with attention deficit disorder. J Pediatr. 1988;113:137–145 · DOI · Paper page
- Varley CK, Trupin EW. Double-blind assessment of stimulant medication for attention deficit disorder: a model for clinical application. Am J Orthopsychiatry. 1983;53:542–547 · DOI
- Van Reekum R, Links PS. N-of-1 study: methylphenidate in a patient with borderline personality disorder and attention deficit hyperactivity disorder. Can J Psychiatry. 1994;39:186–187 · DOI
- Hale JB, Hoeppner JA, DeWitt MB, Coury DL, Ritacco DG, Trommer B. Evaluating medication response in ADHD: cognitive, behavioral, and single-subject methodology. J Learn Disabil. 1998;31:595–607 · DOI
- Guyatt GH, Keller JL, Jaeschke R, Rosenbloom D, Adachi JD, Newhouse MT. The n-of-1 randomized controlled trial: clinical usefulness: our three-year experience. Ann Intern Med. 1990;112:293–299 · DOI · Paper page
- Larson EB, Ellsworth AJ, Oas J. Randomized clinical trials in single patients during a 2-year period. JAMA. 1993;270:2708–2712 · doi:10.1001/jama.270.22.2708
- Shaw K, Mitchell G, Wagner I, Eastwood H. Attitudes and practices of general practitioners in the diagnosis and management of attention deficit hyperactivity disorder. J Paediatr Child Health. 2002;38:481–486 · DOI
- Duggan CM, Mitchell G, Nikles CJ, Glasziou PP, Del Mar CB, Clavarino A. Managing ADHD in general practice: N of 1 trials can help!Aust Fam Physician. 2000;29:1205–1209
- Nikles J, Glasziou P, Del Mar C, Duggan C, Mitchell G. N of 1 trials: practical tools for medication management. Aust Fam Physician. 2000;29:1108–1112
- Nikles CJ, Yelland M, Glasziou PP, Mar CD. Do individualized medication effectiveness tests (n-of-1 trials) change clinical decisions about which drugs to use for osteoarthritis and chronic pain?Am J Ther. 2005;12:92–97 · DOI
- Coxeter P, Schluter P, Eastwood H, Nikles J, Glasziou P. Valerian does not appear to reduce symptoms for patients with chronic insomnia in general practice using a series of randomised n-of-1 trials. Complement Ther Med. 2003;11:215–222 · DOI
- DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York, NY: Guilford Press; 1998 · DOI · Paper page
- Nikles CJ, Clavarino AM, Del Mar CB. Using n-of-1 trials as a clinical tool to improve prescribing. Br J Gen Pract. 2005;55:175–180
- Askew DA. A Study of Research Adequacy in Australian General Practice [PhD thesis]. Herston, Queensland, Australia: School of Population Health, The University of Queensland; 2005
- Varley CK, Trupin EW. Double-blind administration of methylphenidate to mentally retarded children with attention deficit disorder; a preliminary study. Am J Ment Defic. 1982;86:560–566
- March L, Irwig L, Schwarz J, Simpson J, Chock C, Brooks P. n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. BMJ. 1994;309:1041–1045; discussion 1045–1046 · DOI
- Thomson JB, Varley CK. Prediction of stimulant response in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 1998;8:125–132 · DOI
- Kent L. Recent advances in the genetics of attention deficit hyperactivity disorder. Curr Psychiatry Rep. 2004;6:143–148 · DOI
Cited by
The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?
Lillie, E. O., Patay, B., Diamant, J., Issell, B., Topol, E. J., & Schork, N. J. (2011) · Personalized Medicine · doi:10.2217/pme.11.7 · Cited by 706
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Ramstad, E., Krogh, H. B., Nilausen, T. D., Skoog, M., Holmskov, M., Rosendal, S., Groth, C., Magnusson, F. L., Moreira-Maia, C. R., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub2 · Cited by 347
N-of-1 Trials in the Medical Literature: A Systematic Review
Gabler, N. B., Duan, N., Vohra, S., & Kravitz, R. L. (2011) · Medical Care · doi:10.1097/mlr.0b013e318215d90d · Cited by 226
“Wilcoxon signed-rank test 8 (33) w(2) 4 (17)”
N-of-1 (Single-Patient) Trials for Statin-Related Myalgia
Joy, T. R., Monjed, A., Zou, G. Y., Hegele, R. A., McDonald, C. G., & Mahon, J. L. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1921 · Cited by 130
Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Punja, S., Shamseer, L., Hartling, L., Urichuk, L., Vandermeer, B., Nikles, J., & Vohra, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009996.pub2 · Cited by 122
Self-citation
Metadata
- Authors
- Nikles, C. J., Mitchell, G. K., Del Mar, C. B., Clavarino, A., & McNairn, N.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2006-06-01
- Volume
- 117
- Issue
- 6
- Pages
- 2040-2046
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2106001419
- Cited by
- 78
- References
- 6
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.